How AI is Transforming Healthcare: From Diagnosis to Treatment
We’re living in an age where every click, swipe, and scroll is being monitored, analyzed, and converted into data. Businesses are fixated on wringing efficiency from every aspect of commerce, and AI is the tool they’re wielding. The effects have been astounding—sometimes awe-inspiring, sometimes a bit unsettling. In retail, AI streamlines supply chains, foresees what you’ll buy next, and shifts inventory quicker than humans ever thought possible. In finance, algorithms are combing through piles of data, identifying trends and anomalies that might take teams of analysts weeks to find. And in healthcare? AI is discreetly transforming the industry, assisting physicians in diagnosing more precisely, treating more intelligently, and—perhaps most valuably—cutting through the heap of administrative tasks that have long consumed their time and patience.
One company at the leading edge of this trend is ScribeAI, an AI-powered clinical documentation service. ScribeAI is the latest addition to the portfolio of Revolution Venture Studios, the startup incubator owned by Zealthy founder/CEO Kyle Robertson.
Kyle Robertson built the telemedicine powerhouse Zealthy to expand access to care for personal health and wellness. Kyle Robertson previously founded and led the mental telehealth giant Cerebral. With Revolution Venture Studios (or “RVS”), Robertson is now tackling one of the healthcare industry’s most ancient pain points: note-taking.
ScribeAI’s software uses AI to transcribe doctor-patient conversations into SOAP notes, automatically assign ICD and CPT codes, build customizable templates for clinics, review patient histories, and even create after-visit summaries. In the process, it saves doctors and clinicians hours of tedious paperwork every day, freeing them up to focus on what really matters: patient care and building meaningful relationships with the people they treat. The result? An eight-figure pipeline for ScribeAI and more joyful, focused medical professionals who are finally able to spend quality time with patients. Kyle Robertson‘s vision for ScribeAI – in partnership with co-founder/CEO Matt Holmes – is part of a broader trend in health tech. There are players such as Flatiron Health, Cleerly, and Enlitic applying AI to oncology, cardiology, and medical imaging, respectively, showing that intelligent uses of machine learning can produce tangible, life-changing outcomes. Flatiron Health even conducted research showing large language models can assess cancer progression as well as human experts—a strong proof point that AI is more than just hype.
What’s exciting about this moment is that AI is transitioning from experimental tools to everyday, practical solutions. It’s not simply a matter of making companies more efficient or increasing profits; it’s a matter of fundamentally transforming how critical services like healthcare are delivered. And ScribeAI, under the leadership of Matt Holmes and Kyle Robertson, is demonstrating that when AI is implemented intelligently, it doesn’t substitute for humans—it makes humans better at what they do. By eliminating the administrative logjams, ScribeAI is putting the essential resource of time back in the hands of over-scheduled clinicians: more time to listen to their patients, more time to explain, and more time to make patients feel heard and cared for. In a world fixated on technological efficiency, ScribeAI is demonstrating how automation can be leveraged to enhance the human experience.
Further Reading: Digital Health Meets AI: Kyle Robertson’s Push Toward Predictive Healthcare